APA (7th ed.) Citation

Yu, K., Davidson, C. L., Wójtowicz, A., Lisboa, L., Wang, T., Airo, A. M., . . . Yu, K. (2018). LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions. Journal of Clinical Investigation, 128(4), 1523. https://doi.org/10.1172/JCI96174

Chicago Style (17th ed.) Citation

Yu, Kang, et al. "LILRB1 Polymorphisms Influence Posttransplant HCMV Susceptibility and Ligand Interactions." Journal of Clinical Investigation 128, no. 4 (2018): 1523. https://doi.org/10.1172/JCI96174.

MLA (9th ed.) Citation

Yu, Kang, et al. "LILRB1 Polymorphisms Influence Posttransplant HCMV Susceptibility and Ligand Interactions." Journal of Clinical Investigation, vol. 128, no. 4, 2018, p. 1523, https://doi.org/10.1172/JCI96174.